Hereditary Ataxia: Causes, Symptoms and Treatment

What is Hereditary Ataxia?

Hereditary ataxia (also called heredoataxia) encompasses a diverse group of genetically caused neurological diseases characterized by progressive impairment of movement coordination (ataxia). The term combines the Latin hredo (inheritance) and the Greek ataxia (disorder, lack of order). These conditions primarily affect the cerebellum, cerebellar pathways, and the spinal cord, resulting in gradually worsening motor dysfunction.

Hereditary ataxias are classified as rare diseases and can manifest at any age, although many forms begin in childhood or early adulthood. The most clinically recognized subgroups include the spinocerebellar ataxias (SCA) and Friedreich ataxia.

Causes and Genetic Basis

Hereditary ataxias are caused by mutations in specific genes essential for the survival and function of neurons. The clinical presentation varies considerably depending on the gene affected and the mode of inheritance.

• Autosomal dominant hereditary ataxias: This group includes the spinocerebellar ataxias (SCA types 1-48+), where a single copy of the mutated gene is sufficient to cause disease. Many are caused by trinucleotide repeat expansions.
• Autosomal recessive hereditary ataxias: Friedreich ataxia is the most common form in this category. Both copies of the gene must be affected. It is most often caused by a GAA repeat expansion in the FXN gene, which encodes the protein frataxin.
• X-linked forms: Less common examples include the Fragile X-associated Tremor/Ataxia Syndrome (FXTAS).
• Mitochondrial ataxias: Caused by mutations in mitochondrial DNA that impair energy metabolism in nerve cells.

Symptoms

Symptoms typically develop gradually and worsen over years to decades. Common manifestations include:

• Gait disturbances: Unsteady, wide-based walking with staggering (cerebellar gait)
• Limb incoordination: Difficulty with grasping, writing, or fine motor tasks (dysmetria)
• Speech difficulties: Slurred or scanning speech (dysarthria)
• Eye movement abnormalities: Involuntary eye movements (nystagmus), impaired smooth pursuit
• Muscle weakness and spasticity (depending on subtype)
• Sensory disturbances: Numbness or tingling in the hands and feet
• Cardiac involvement: Especially in Friedreich ataxia (hypertrophic cardiomyopathy)
• Cognitive impairment may develop over time in some forms

Diagnosis

Diagnosing hereditary ataxia requires a thorough clinical evaluation combined with several diagnostic investigations.

Clinical Examination

A neurologist assesses gait, coordination, reflexes, and eye movements. Standard tests include the finger-nose test and the heel-shin test to evaluate coordination deficits.

Neuroimaging

Magnetic resonance imaging (MRI) of the brain and spinal cord frequently reveals atrophy of the cerebellum or brainstem, providing important clues about the subtype.

Genetic Testing

Molecular genetic analysis is the gold standard for definitive diagnosis. Targeted gene sequencing or multi-gene ataxia panels can identify the specific mutation responsible. Genetic counseling is strongly recommended for patients and their families.

Additional Investigations

• Electrophysiology: Nerve conduction studies (NCS) and evoked potentials to assess nerve function
• Echocardiography: Cardiac evaluation, especially important in Friedreich ataxia
• Laboratory tests: To exclude acquired causes such as vitamin E deficiency or gluten ataxia

Treatment

For most forms of hereditary ataxia, no disease-modifying cure currently exists. Management focuses on symptom relief and maintaining quality of life.

Pharmacological Therapy

• For Friedreich ataxia, omaveloxolone (Skyclarys) received FDA approval in 2023 as the first disease-modifying therapy. It activates the Nrf2 pathway, improving mitochondrial function and reducing oxidative stress.
• Symptomatic medications may address spasticity (e.g., baclofen), tremor, or cardiac complications.

Physiotherapy and Exercise

Physiotherapy is a cornerstone of management. Targeted balance and coordination training helps preserve motor function and reduces the risk of falls.

Speech and Language Therapy

Speech therapy addresses dysarthria and dysphagia, supporting effective communication and safe swallowing.

Occupational Therapy

Occupational therapy helps patients maintain independence in daily activities through adaptive techniques and assistive devices.

Psychosocial Support

As hereditary ataxias follow a chronic progressive course, psychological support and access to patient organizations (e.g., National Ataxia Foundation) are essential for both patients and caregivers.

Prognosis and Disease Course

The prognosis varies considerably depending on the specific subtype and age of onset. Many forms progress slowly; some patients eventually require a wheelchair after years of disease progression. Other forms may have a relatively benign course. Regular neurological follow-up is essential to monitor progression and adapt the treatment plan accordingly.

References

1. Klockgether T. - Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurology, 2010.
2. Bhidayasiri R., Perlman SL., Pulst SM., Geschwind DH. - Late-onset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature. Archives of Neurology, 2005.
3. National Ataxia Foundation - What is Ataxia? Patient Information Resource. www.ataxia.org (accessed 2024).